Novel Multiplex Immunoassays for Quantification of IgG against Group B <italic toggle="yes">Streptococcus</italic> Capsular Polysaccharides in Human Sera

ABSTRACT Group B Streptococcus (GBS) infections constitute a major cause of invasive disease during the first three months of life and an unmet medical need that could be addressed by maternal vaccination. The GBS capsular polysaccharides (CPSs) have shown promise as vaccine targets in clinical stud...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Giada Buffi, Bruno Galletti, Maria Stella, Daniela Proietti, Evita Balducci, Maria Rosaria Romano, Elena Mori, Monica Fabbrini, Marzia Monica Giuliani, Francesco Berti, Immaculada Margarit
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2019
Materias:
GBS
Acceso en línea:https://doaj.org/article/cc73657a23bd4115914741b7c472452e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cc73657a23bd4115914741b7c472452e
record_format dspace
spelling oai:doaj.org-article:cc73657a23bd4115914741b7c472452e2021-11-15T15:22:26ZNovel Multiplex Immunoassays for Quantification of IgG against Group B <italic toggle="yes">Streptococcus</italic> Capsular Polysaccharides in Human Sera10.1128/mSphere.00273-192379-5042https://doaj.org/article/cc73657a23bd4115914741b7c472452e2019-08-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSphere.00273-19https://doaj.org/toc/2379-5042ABSTRACT Group B Streptococcus (GBS) infections constitute a major cause of invasive disease during the first three months of life and an unmet medical need that could be addressed by maternal vaccination. The GBS capsular polysaccharides (CPSs) have shown promise as vaccine targets in clinical studies. A highly specific serological assay to quantify maternal and neonatal anti-CPS antibody levels will be instrumental for GBS vaccine licensure. Here, we describe the development and comparison of two novel multiplex immunoassays (MIAs) based on the Luminex technology for the quantification of IgG antibodies recognizing the five most frequent GBS capsular variants (Ia, Ib, II, III, and V) out of the ten types identified. The first assay is based on the use of biotinylated CPSs coupled to streptavidin-derivatized magnetic microspheres (Biotin-CPS MIA), while the second is a sandwich assay with plain CPSs coupled to magnetic microspheres coated with polysaccharide-specific mouse monoclonal antibodies (Sandwich MIA). Both assays showed good specificity, linearity, and precision, although the Biotin-CPS MIA presented higher sensitivity and lower complexity than the Sandwich MIA. A panel of human sera representing a wide range of anti-CPS IgG concentrations was tested in parallel by the two assays, which resulted in comparable titers. Our data support the preservation of antigenic epitopes in the biotinylated polysaccharides and the suitability of the Biotin-CPS MIA for the precise determination of GBS anti-CPS IgG concentrations in human sera. IMPORTANCE Group B streptococcal infections can cause death in neonates up to 3 months of age. Intrapartum antibiotic prophylaxis in GBS-colonized mothers has limited early infections but has no impact after the first week of life. The development of a maternal vaccine to address this unmet medical need has been identified as a priority by the World Health Organization, and the GBS CPSs are considered the best antigen targets. However, to date there are no accepted standardized assays to measure immune responses to the investigational vaccines and for establishment of serocorrelates of protection. Here, we describe the performance of two microsphere-based pentaplex immunoassays for the determination of antibodies recognizing the five most frequent GBS serotypes. Our data confirm that an assay based on biotinylated polysaccharides coupled to streptavidin microspheres would be suitable for the intended purpose.Giada BuffiBruno GallettiMaria StellaDaniela ProiettiEvita BalducciMaria Rosaria RomanoElena MoriMonica FabbriniMarzia Monica GiulianiFrancesco BertiImmaculada MargaritAmerican Society for MicrobiologyarticleGBScapsular polysaccharidesimmunoassaymultiplexneonatal infectionMicrobiologyQR1-502ENmSphere, Vol 4, Iss 4 (2019)
institution DOAJ
collection DOAJ
language EN
topic GBS
capsular polysaccharides
immunoassay
multiplex
neonatal infection
Microbiology
QR1-502
spellingShingle GBS
capsular polysaccharides
immunoassay
multiplex
neonatal infection
Microbiology
QR1-502
Giada Buffi
Bruno Galletti
Maria Stella
Daniela Proietti
Evita Balducci
Maria Rosaria Romano
Elena Mori
Monica Fabbrini
Marzia Monica Giuliani
Francesco Berti
Immaculada Margarit
Novel Multiplex Immunoassays for Quantification of IgG against Group B <italic toggle="yes">Streptococcus</italic> Capsular Polysaccharides in Human Sera
description ABSTRACT Group B Streptococcus (GBS) infections constitute a major cause of invasive disease during the first three months of life and an unmet medical need that could be addressed by maternal vaccination. The GBS capsular polysaccharides (CPSs) have shown promise as vaccine targets in clinical studies. A highly specific serological assay to quantify maternal and neonatal anti-CPS antibody levels will be instrumental for GBS vaccine licensure. Here, we describe the development and comparison of two novel multiplex immunoassays (MIAs) based on the Luminex technology for the quantification of IgG antibodies recognizing the five most frequent GBS capsular variants (Ia, Ib, II, III, and V) out of the ten types identified. The first assay is based on the use of biotinylated CPSs coupled to streptavidin-derivatized magnetic microspheres (Biotin-CPS MIA), while the second is a sandwich assay with plain CPSs coupled to magnetic microspheres coated with polysaccharide-specific mouse monoclonal antibodies (Sandwich MIA). Both assays showed good specificity, linearity, and precision, although the Biotin-CPS MIA presented higher sensitivity and lower complexity than the Sandwich MIA. A panel of human sera representing a wide range of anti-CPS IgG concentrations was tested in parallel by the two assays, which resulted in comparable titers. Our data support the preservation of antigenic epitopes in the biotinylated polysaccharides and the suitability of the Biotin-CPS MIA for the precise determination of GBS anti-CPS IgG concentrations in human sera. IMPORTANCE Group B streptococcal infections can cause death in neonates up to 3 months of age. Intrapartum antibiotic prophylaxis in GBS-colonized mothers has limited early infections but has no impact after the first week of life. The development of a maternal vaccine to address this unmet medical need has been identified as a priority by the World Health Organization, and the GBS CPSs are considered the best antigen targets. However, to date there are no accepted standardized assays to measure immune responses to the investigational vaccines and for establishment of serocorrelates of protection. Here, we describe the performance of two microsphere-based pentaplex immunoassays for the determination of antibodies recognizing the five most frequent GBS serotypes. Our data confirm that an assay based on biotinylated polysaccharides coupled to streptavidin microspheres would be suitable for the intended purpose.
format article
author Giada Buffi
Bruno Galletti
Maria Stella
Daniela Proietti
Evita Balducci
Maria Rosaria Romano
Elena Mori
Monica Fabbrini
Marzia Monica Giuliani
Francesco Berti
Immaculada Margarit
author_facet Giada Buffi
Bruno Galletti
Maria Stella
Daniela Proietti
Evita Balducci
Maria Rosaria Romano
Elena Mori
Monica Fabbrini
Marzia Monica Giuliani
Francesco Berti
Immaculada Margarit
author_sort Giada Buffi
title Novel Multiplex Immunoassays for Quantification of IgG against Group B <italic toggle="yes">Streptococcus</italic> Capsular Polysaccharides in Human Sera
title_short Novel Multiplex Immunoassays for Quantification of IgG against Group B <italic toggle="yes">Streptococcus</italic> Capsular Polysaccharides in Human Sera
title_full Novel Multiplex Immunoassays for Quantification of IgG against Group B <italic toggle="yes">Streptococcus</italic> Capsular Polysaccharides in Human Sera
title_fullStr Novel Multiplex Immunoassays for Quantification of IgG against Group B <italic toggle="yes">Streptococcus</italic> Capsular Polysaccharides in Human Sera
title_full_unstemmed Novel Multiplex Immunoassays for Quantification of IgG against Group B <italic toggle="yes">Streptococcus</italic> Capsular Polysaccharides in Human Sera
title_sort novel multiplex immunoassays for quantification of igg against group b <italic toggle="yes">streptococcus</italic> capsular polysaccharides in human sera
publisher American Society for Microbiology
publishDate 2019
url https://doaj.org/article/cc73657a23bd4115914741b7c472452e
work_keys_str_mv AT giadabuffi novelmultipleximmunoassaysforquantificationofiggagainstgroupbitalictoggleyesstreptococcusitaliccapsularpolysaccharidesinhumansera
AT brunogalletti novelmultipleximmunoassaysforquantificationofiggagainstgroupbitalictoggleyesstreptococcusitaliccapsularpolysaccharidesinhumansera
AT mariastella novelmultipleximmunoassaysforquantificationofiggagainstgroupbitalictoggleyesstreptococcusitaliccapsularpolysaccharidesinhumansera
AT danielaproietti novelmultipleximmunoassaysforquantificationofiggagainstgroupbitalictoggleyesstreptococcusitaliccapsularpolysaccharidesinhumansera
AT evitabalducci novelmultipleximmunoassaysforquantificationofiggagainstgroupbitalictoggleyesstreptococcusitaliccapsularpolysaccharidesinhumansera
AT mariarosariaromano novelmultipleximmunoassaysforquantificationofiggagainstgroupbitalictoggleyesstreptococcusitaliccapsularpolysaccharidesinhumansera
AT elenamori novelmultipleximmunoassaysforquantificationofiggagainstgroupbitalictoggleyesstreptococcusitaliccapsularpolysaccharidesinhumansera
AT monicafabbrini novelmultipleximmunoassaysforquantificationofiggagainstgroupbitalictoggleyesstreptococcusitaliccapsularpolysaccharidesinhumansera
AT marziamonicagiuliani novelmultipleximmunoassaysforquantificationofiggagainstgroupbitalictoggleyesstreptococcusitaliccapsularpolysaccharidesinhumansera
AT francescoberti novelmultipleximmunoassaysforquantificationofiggagainstgroupbitalictoggleyesstreptococcusitaliccapsularpolysaccharidesinhumansera
AT immaculadamargarit novelmultipleximmunoassaysforquantificationofiggagainstgroupbitalictoggleyesstreptococcusitaliccapsularpolysaccharidesinhumansera
_version_ 1718428033091633152